Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function

American Surgeon

Volumn 77, Issue 7, 2011, Pages 922-928

  Eagle, Susan ^a   Brophy, Colleen M ^a,b   Komalavilas, Padmini ^a,b   Hocking, Kyle ^a   Putumbaka, Gowthami ^a   Osgood, Michael ^a   Sexton, Kevin ^a   Leacche, Marzia ^a   Cheung Flynn, Joyce ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; CARBACHOL; METHYLENE BLUE; NORADRENALIN;

ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HUMAN; HUMAN TISSUE; MEMBRANE DEPOLARIZATION; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; SAPHENOUS VEIN GRAFT; SKIN SCAR; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN GRAFT DISEASE;

COLORING AGENTS; CORONARY ARTERY BYPASS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PREOPERATIVE CARE; SAPHENOUS VEIN; SKIN; VASCULAR SURGICAL PROCEDURES;

EID: 80052047797     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lopes RD, Hafley GE, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med 2009;361:235-44.
2. Wallitt EJ, Jevon M, Hornick PI. Therapeutics of vein graft intimal hyperplasia: 100 years on. Ann Thorac Surg 2007;84:317-23. (Pubitemid 46921110)
3. Wu J, Zhang C. Neointimal hyperplasia, vein graft remodeling, and long-term patency. Am J Physiol Heart Circ Physiol 2009;297:H1194-5.
4. Rousou LJ, Taylor KB, Lu XG, et al. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. Ann Thorac Surg 2009;87:62-70.
5. Grohs JG, Kadletz M, Wodratzka M, et al. Contractile function of human veins after long-term storage in different media. J Cardiovasc Pharmacol 1996;28:89-93. (Pubitemid 26190460)
6. Raja SG, Haider Z, Ahmad M, Zaman H. Saphenous vein grafts: To use or not to use? Heart Lung Circ 2004;13:403-9.
7. Barber DA, Rubin JW, Zumbro GL, Tackett RL. The use of methylene blue as an extravascular surgical marker impairs vascular responses of human saphenous veins. J Thorac Cardiovasc Surg 1995;109:21-9.
8. Shoemaker K, Rubin J, Zumbro GL, Tackett R. Evans blue and gentian violet: Alternatives to methylene blue as a surgical marker dye. J Thorac Cardiovasc Surg 1996;112:542-4. (Pubitemid 26301870)
9. Wingard CJ, Browne AK, Murphy RA. Dependence of force on length at constant cross-bridge phosphorylation in the swine carotid media. J Physiol 1995;488:729-39.
10. Bai TR, Bates JH, Brusasco V, et al. On the terminology for describing the length-force relationship and its changes in airway smooth muscle. J Appl Physiol 2004;97:2029-34. (Pubitemid 39552438)
11. Herlihy JT, Murphy RA. Length-tension relationship of smooth muscle of the hog carotid artery. Circ Res 1973;33:275-83.
12. Hocking KM, Brophy CM, Rizvi SZ, et al. Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins. J Vasc Surg 2011;53:454-60.
13. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6. (Pubitemid 11169009)
14. Khalil RA, Crews JK, Novak J, et al. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 1998;31:1065-9. (Pubitemid 28191498)
15. Viaro F, Capellini VK, Celotto AC, et al. Immunohistochemical evaluation of three nitric oxide synthase isoforms in human saphenous vein exposed to different degrees of distension pressures. Cardiovasc Pathol 2010;19:e211-20.
16. Conte MS. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin Vasc Surg 2009;22:227-33.
17. Halabi AR, Alexander JH, Shaw LK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 2005;96:1254-9. (Pubitemid 41505404)
18. Fabricius AM, Gerber W, Hanke M, et al. Early angiographic control of perioperative ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg 2001;19:853-8. (Pubitemid 32519583)
19. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26. (Pubitemid 26288642)
20. Tsui JC, Souza DS, Filbey D, et al. Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel "no-touch"technique: potential role of nitric oxide contribution to improved early graft patency rates. J Vasc Surg 2002;35:356-62. (Pubitemid 44718645)
21. Dashwood MR, Savage K, Dooley A, et al. Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production. Ann Thorac Surg 2005;80:939-44. (Pubitemid 41196788)
22. Manchio JV, Gu J, Romar L, et al. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery. Ann Thorac Surg 2005;79:1991-8. (Pubitemid 40804176)
23. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793-801.
24. Poston R, Gu J, Brown J, et al. Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass. J Cardiothorac Vasc Anesth 2005;19:11-8. (Pubitemid 40254281)
25. Kobayashi T, Makuuchi H, Naruse Y, et al. Assessment of saphenous vein graft wall characteristics with intravascular ultrasound imaging. Jpn J Thorac Cardiovasc Surg 1998;46:701-6.
26. Yamada T, Itoh T, Nakano S, Tokunaga O. Time-dependent thickening of the intima in aortocoronary saphenous vein grafts: clinicopathological analysis of 24 patients. Heart Vessels 1995;10:41-5.
27. Sharony R, Pintucci G, Saunders PC, et al. Matrix metalloproteinase expression in vein grafts: Role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol 2006;290:H1651-9.
28. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: PREVENT IVA randomized controlled trial. JAMA 2005;294:2446-54. (Pubitemid 41627922)
29. Chu WW, Rha SW, Kuchulakanti PK, et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-7. (Pubitemid 41828119)
30. Johansson BL, Souza DS, Bodin L, et al. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: An angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg 2010;38:414-9.
31. Davies MG, Hagen PO. Influence of perioperative storage solutions on long-term vein graft function and morphology. Ann Vasc Surg 1994;8:150-7. (Pubitemid 24113391)
32. Martinez TT, Jaeger RW, DeCastro FJ, et al. A comparison of the absorption and metabolism of isopropyl alcohol by oral, dermal and inhalation routes. Vet Hum Toxicol 1986;28:233-6. (Pubitemid 16035906)
33. Kapp RW Jr, Bevan C, Gardiner TH, et al. Isopropanol: Summary of TSCA test rule studies and relevance to hazard identification. Regul Toxicol Pharmacol 1996;23:183-92. (Pubitemid 26308974)
34. Allali-Hassani A, Martinez SE, Peralba JM, et al. Alcohol dehydrogenase of human and rat blood vessels. Role in ethanol metabolism. FEBS Lett 1997;405:26-30. (Pubitemid 27130366)
35. Farber A, Major K, Wagner WH, et al. Cryopreserved saphenous vein allografts in infrainguinal revascularization: Analysis of 240 grafts. J Vasc Surg 2003;38:15-21. (Pubitemid 41123281)